[go: up one dir, main page]

FI863626L - Dna-sekvenser, rekombinant-dna -molekyler och foerfaranden foer framstaellning av polypeptider som liknar humant lipokortin. - Google Patents

Dna-sekvenser, rekombinant-dna -molekyler och foerfaranden foer framstaellning av polypeptider som liknar humant lipokortin. Download PDF

Info

Publication number
FI863626L
FI863626L FI863626A FI863626A FI863626L FI 863626 L FI863626 L FI 863626L FI 863626 A FI863626 A FI 863626A FI 863626 A FI863626 A FI 863626A FI 863626 L FI863626 L FI 863626L
Authority
FI
Finland
Prior art keywords
dna
molekyler
lipokortin
liknar
polypeptider
Prior art date
Application number
FI863626A
Other languages
English (en)
Other versions
FI863626A7 (fi
FI863626A0 (fi
Inventor
Barbara P Wallner
Blake R Pepinsky
Jeffrey L Garwin
Daniel G Schindler
Kuo-Seng Huang
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/690,146 external-priority patent/US4879224A/en
Priority claimed from US06/712,376 external-priority patent/US4874743A/en
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of FI863626L publication Critical patent/FI863626L/fi
Publication of FI863626A7 publication Critical patent/FI863626A7/fi
Publication of FI863626A0 publication Critical patent/FI863626A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI863626A 1985-01-10 1986-01-10 Dna-sekvenser, rekombinant-dna -molekyler och foerfaranden foer framstaellning av polypeptider som liknar humant lipokortin. FI863626A0 (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US06/690,146 US4879224A (en) 1985-01-10 1985-01-10 DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
US06/712,376 US4874743A (en) 1985-01-10 1985-03-15 DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor-like polypeptides
US76587785A 1985-08-14 1985-08-14
US77289285A 1985-09-05 1985-09-05
PCT/US1986/000027 WO1986004094A1 (en) 1985-01-10 1986-01-10 Dna sequences, recombinant dna molecules and processes for producing human lipocortin-like polypeptides

Publications (3)

Publication Number Publication Date
FI863626L true FI863626L (fi) 1986-09-09
FI863626A7 FI863626A7 (fi) 1986-09-09
FI863626A0 FI863626A0 (fi) 1986-09-09

Family

ID=27505426

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863626A FI863626A0 (fi) 1985-01-10 1986-01-10 Dna-sekvenser, rekombinant-dna -molekyler och foerfaranden foer framstaellning av polypeptider som liknar humant lipokortin.

Country Status (11)

Country Link
EP (1) EP0209568B1 (fi)
JP (4) JPH0787789B2 (fi)
CN (1) CN86100721A (fi)
AT (1) ATE108830T1 (fi)
AU (1) AU601676B2 (fi)
DE (1) DE3689977T2 (fi)
DK (1) DK433686A (fi)
ES (1) ES8704184A1 (fi)
FI (1) FI863626A0 (fi)
HU (1) HUT40695A (fi)
WO (1) WO1986004094A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5770786A (en) * 1985-04-15 1986-11-05 Biotechnology Research Partners Limited Human anti-inflammatory phospholipase inhibitor protein
US5264550A (en) * 1985-04-15 1993-11-23 Scios Nova Inc. Human anti-inflammatory phospholipase inhibitor protein
JPS6256429A (ja) * 1985-09-04 1987-03-12 Teijin Ltd フオスフオリパ−ゼａ↓２阻害活性を有する蛋白
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
EP0285405A1 (en) * 1987-03-31 1988-10-05 Schering Biotech Corporation Glycosylation inhibition factors
JPH06799B2 (ja) * 1987-04-02 1994-01-05 帝人株式会社 起炎性フオスフオリパ−ゼａ▲下２▼阻害活性を有する蛋白
DE3737237A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Anticoagulatorisches protein pp4-x, seine herstellung und verwendung
US5320950A (en) * 1987-11-03 1994-06-14 Behringwerke Aktiengesellschaft DNA encoding anticoagulative protein PP4-X, and its preparation and use
JPH01199995A (ja) * 1988-02-04 1989-08-11 Kyowa Hakko Kogyo Co Ltd ホスホリパーゼａ↓２阻害ペプチド
US5733732A (en) * 1996-01-03 1998-03-31 University Of Iowa Research Foundation Methods for detecting primary adhalinopathy
CA2219299A1 (en) * 1997-10-24 1999-04-24 Elias Georges P-40, a new member of the multidrug resistance gene family
KR100835879B1 (ko) * 2006-10-10 2008-06-09 학교법인 한림대학교 아넥신 융합 단백질
GB2542391A (en) 2015-09-17 2017-03-22 Annexin Pharmaceuticals Ab Process of manufacture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239780A (en) * 1979-10-11 1980-12-16 The Upjohn Company Phospholipase A2 inhibition
US4537858A (en) * 1984-06-22 1985-08-27 E. R. Squibb & Sons, Inc. Plastatin
AU5770786A (en) * 1985-04-15 1986-11-05 Biotechnology Research Partners Limited Human anti-inflammatory phospholipase inhibitor protein

Also Published As

Publication number Publication date
CN86100721A (zh) 1987-02-11
DE3689977D1 (de) 1994-08-25
EP0209568A1 (en) 1987-01-28
EP0209568B1 (en) 1994-07-20
AU5318286A (en) 1986-07-29
JPH07101994A (ja) 1995-04-18
JPH0789996A (ja) 1995-04-04
ATE108830T1 (de) 1994-08-15
HUT40695A (en) 1987-01-28
DE3689977T2 (de) 1994-10-27
DK433686D0 (da) 1986-09-10
FI863626A7 (fi) 1986-09-09
AU601676B2 (en) 1990-09-20
DK433686A (da) 1986-09-10
WO1986004094A1 (en) 1986-07-17
EP0209568A4 (en) 1988-10-27
ES8704184A1 (es) 1987-03-16
JPH0787980A (ja) 1995-04-04
JPS62501679A (ja) 1987-07-09
ES550784A0 (es) 1987-03-16
FI863626A0 (fi) 1986-09-09
JPH0787789B2 (ja) 1995-09-27

Similar Documents

Publication Publication Date Title
FI864949L (fi) Fluorerade akrylmonomerer, polymerer haerledda daerav och anvaendning av dessa som hydrofoba och oleofoba aemnen.
FI861510A7 (fi) Benzonaftalenderivater, deras framstaellning och anvaendning som farmaceutiska och kosmetiska aemnen.
FI863755L (fi) Foerfarande foer framstaellning av vattenloesliga sampolymerer innehaollande vinylaminenheter och anvaendning av dessa som vaot- och torrstyrkemedel foer papper.
FI864923A7 (fi) Engaongsbloeja som omfattar spaennmedel foer grendelen foer foerbaettring av laeckagebestaendigheten och passformen.
FI864904A7 (fi) Tryckt dataremsa, som innhaoller bitkodad information och styrning av skanner.
FI860265L (fi) Anvaendning av en fibervaev innefattande mikrosfaerer foer tillverkning av foerstaerkta foeremaol, foerstaerkta foeremaol och saett foer tillverkning av en fibervaev innefattande mikrosfaerer.
FI861251L (fi) Foerfarande foer extrahering och rengoering av proteiner fraon en kultur som producerar dessa.
FI862727L (fi) Vattenbaserade, av flere komponenter bestaoende polymerkompositioner och foerfarande foer framstaellning av dessa.
FI860842A7 (fi) Labdan-derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI860945A7 (fi) ^-laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som och i laekemedel.
FI863630L (fi) Linshaollare, speciellt haollare foer glasoegonlinser som skall renas och daerefter belaeggas.
FI865264L (fi) Foerfarande foer anvaendning av en spektralskiftskaernreaktor och en kaernreaktor, i vilken anvaends vatten undantraengande knippen.
FI862374A7 (fi) Foerfarande och anordning foer rundning av plaot, saerskilt foer doskroppar.
FI860199A7 (fi) Tricykliska foereningar, dessa innehaollande kompositioner, foerfarande foer deras framstaellning och vaordfoerfarande medelst anvaendning av dessa.
FI863155A0 (fi) Foerfarande foer framstaellning av kefalosporinsalter och injekterbara kompositioner som innehaoller detsamma.
FI864164L (fi) Biologiskt aktiva derivat av human- -interferon, deras framstaellning och laekemedel, som innehaoller dylika derivat.
FI863626L (fi) Dna-sekvenser, rekombinant-dna -molekyler och foerfaranden foer framstaellning av polypeptider som liknar humant lipokortin.
FI871270A7 (fi) L-dopa-derivat, foerfarande foer framstaellning av dem och farmaceutiska sammansaettningar som innehaoller dem.
FI875359L (fi) Vaermehaerdbara sammansaettningar anvaendbara som b-steg, foerfarande foer deras framstaellning och anvaendning av dessa sammansaettningar.
FI860121A7 (fi) Foerfarande och anordning foer loesbrytning av avlagring och murverk i liggande cylindrar, saerskilt i roterugnar.
FI861045A7 (fi) B-laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI863537A0 (fi) Dihydropyridin-2-hydroxyaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI863550A0 (fi) Ksantinderivator, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI853787A0 (fi) Elektronisk fjaerrstyrnings- och fjaerrmaetningssystem, speciellt foer foerutsaegning och styrning av foeroreningsaemnen.
FI853854A0 (fi) Jodtriaminobenzenfoereningar, foerfarande foer deras framstaellning och deras anvaendning som kontrastmedel foer roentgenstraolar.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BIOGEN N.V.